These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3533178

  • 1. Variables influencing the timing of marrow transplantation in patients with chronic myelogenous leukemia.
    Segel GB, Simon W, Lichtman MA.
    Blood; 1986 Nov; 68(5):1055-64. PubMed ID: 3533178
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation.
    McGlave P, Arthur D, Haake R, Hurd D, Miller W, Vercellotti G, Weisdorf D, Kim T, Ramsay N, Kersey J.
    J Clin Oncol; 1987 Jul; 5(7):1033-40. PubMed ID: 3298558
    [Abstract] [Full Text] [Related]

  • 4. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
    Gratwohl A, Hermans J, Niederwieser D, Frassoni F, Arcese W, Gahrton G, Bandini G, Carreras E, Vernant JP, Bosi A.
    Bone Marrow Transplant; 1993 Nov; 12(5):509-16. PubMed ID: 8298562
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Bone marrow transplantation as therapy in chronic myeloid leukemia].
    Schmeiser T, Arnold R, Wiesneth M, Hertenstein B, Bunjes D, Anger B, Heit W, Heimpel H.
    Dtsch Med Wochenschr; 1988 Jan 08; 113(1):6-10. PubMed ID: 3275532
    [Abstract] [Full Text] [Related]

  • 7. Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis.
    Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH.
    Ann Intern Med; 1997 Dec 15; 127(12):1080-8. PubMed ID: 9412310
    [Abstract] [Full Text] [Related]

  • 8. Marrow transplantation for the treatment of chronic myelogenous leukemia.
    Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, Buckner CD, Cheever MA, Deeg HJ, Doney K.
    Ann Intern Med; 1986 Feb 15; 104(2):155-63. PubMed ID: 3511810
    [Abstract] [Full Text] [Related]

  • 9. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.
    Simon W, Segel GB, Lichtman MA.
    Blood Cells Mol Dis; 2006 Feb 15; 37(2):116-24; discussion 125-7. PubMed ID: 16904348
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry.
    Giralt S, Szydlo R, Goldman JM, Veum-Stone J, Biggs JC, Herzig RH, Klein JP, McGlave PB, Schiller G, Gale RP, Rowlings PA, Horowitz MM.
    Blood; 2000 Jan 15; 95(2):410-5. PubMed ID: 10627443
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of genetic markers in chronic myelogenous leukemia patients after bone marrow transplantation.
    Zámecníková A, Kri an P, Mistrík M.
    Neoplasma; 2000 Jan 15; 47(5):299-302. PubMed ID: 11130247
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase.
    Gale RP, Park RE, Dubois RW, Herzig GP, Hocking WG, Horowitz MM, Keating A, Kempin S, Linker CA, Schiffer CA, Wiernik PH, Weisdorf DJ, Rai KR.
    Leuk Res; 1999 Sep 15; 23(9):817-26. PubMed ID: 10475621
    [Abstract] [Full Text] [Related]

  • 16. Terminal-phase chronic myelogenous leukemia: approaches to treatment.
    Allen SL, Coleman M.
    Cancer Invest; 1985 Sep 15; 3(5):491-503. PubMed ID: 3902166
    [Abstract] [Full Text] [Related]

  • 17. Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemia.
    Vellekoop L, Zander AR, Kantarjian HM, Jagannath S, Hester JP, Trujillo J, McCredie KB, Zagars G, Spitzer G, Dicke KA.
    J Clin Oncol; 1986 Jun 15; 4(6):906-11. PubMed ID: 3519881
    [Abstract] [Full Text] [Related]

  • 18. Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome.
    Beelen DW, Graeven U, Elmaagacli AH, Niederle N, Kloke O, Opalka B, Schaefer UW.
    Blood; 1995 May 15; 85(10):2981-90. PubMed ID: 7742558
    [Abstract] [Full Text] [Related]

  • 19. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    van Rhee F, Szydlo RM, Hermans J, Devergie A, Frassoni F, Arcese W, de Witte T, Kolb HJ, Niederwiser D, Jacobsen N, Gahrton G, Bandini G, Carreras E, Bacigalupo A, Michallet M, Ruutu T, Reiffers J, Goldman JM, Apperley J, Gratwohl A.
    Bone Marrow Transplant; 1997 Oct 15; 20(7):553-60. PubMed ID: 9337056
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.
    Roth MS, Antin JH, Ash R, Terry VH, Gotlieb M, Silver SM, Ginsburg D.
    Blood; 1992 Jan 01; 79(1):276-82. PubMed ID: 1728316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.